Pharmaceuticals
Search documents
X @Cointelegraph
Cointelegraph· 2026-07-22 00:20
🇺🇸 TODAY: President Trump says generic drug tariffs will stay at 0% for two years starting August 1, before rising to 100% and eventually 200%, to push pharmaceutical production back to the US. https://t.co/EDfzFSiSPL ...
X @Bloomberg
Bloomberg· 2026-07-21 23:15
The US plans to impose a 100% tariff on imported generic drugs beginning in 2028, Trump says https://t.co/ufeD4yRvtI ...
Rebound in Chipmakers Gathers Pace | The Close 7/21/2026
Bloomberg Television· 2026-07-21 22:10
>> THE COUNTDOWN IS ON, EVERYTHING YOU NEED TO KNOW TO GET THE EDGE AT THE END OF THE MARKET DAY, THIS IS "THE CLOSE." ROMAINE: CHIP STOCKS BOUNCE HIGHER BUT SO TOO DO OIL AND TREASURY YIELDS. LIVE FROM BLOOMBERG HEADQUARTERS IN NEW YORK I’'M ROMAINE BOSTICK. KATIE: I AM KATIE GREIFELD.KICKING OFF THE CLOSING BELL. INTERESTING BOARD TODAY, BECAUSE WHAT IS HAPPENING IS DISCONNECTED FROM WHAT IS HAPPENING DOWN HERE. YOU THINK OF THE EQUITY MARKET, THE S&P 500 IS HIGHER BY ABOUT .9% RIGHT NOW.COMING BACK TO WH ...
Market Today: Novo Nordisk Sues Eli Lilly; GM Profits Surge; AMD, Nebius Jump
GuruFocus· 2026-07-21 22:01
[music] This is Guru Focus Market Today, your afternoon market brief for Tuesday, July 21. Here's where things stand. US stocks rebounded sharply as semiconductor shares led the rally with the Dow Jones Industrial Average climbing nearly 400 points and the S&P 500 snapping a 3-day losing streak.Chipmakers were the session's primary drivers with notable gains from advanced micro devices and Nebus. The surge in technology stocks helped offset recent market weakness and renewed investor optimism in the sector. ...
Novartis CEO on 2Q Profit Beat, Investing in Pipeline
Bloomberg Television· 2026-07-21 21:16
The headline here bars is the return to sales growth in the most recent quarter, a reaffirmation of your full year guidance. But still some questions that with such a big beat this quarter, why not raise the guidance for the full year. Yeah, thanks for the time, Romina.I really feel like this year has been a tale of two sides. On the first half of the year, we needed to navigate these expertise, largest expertise in our history, and then we get into the second half to a period of now growth that we expect t ...
Novartis CEO on Q2 earnings beat and patent expiries
CNBC Television· 2026-07-21 21:00
Yeah, I think when we looked at it and we looked at the opportunities that we have to continue to invest in R&D, we had some cost phasing as well, we thought the prudent approach for now, especially in a year where we face so many generic expertise uh was to hold the guidance where it is, continue to invest in the pipeline. I mean really the story for us goes into the second half where we have six major readouts, pipeline readouts, uh which could really reshape uh the future of the of the company and allow ...
X @The Economist
The Economist· 2026-07-21 20:00
Some microdosing—in other words, taking less than the recommended amount—is routine. Where things get trickier is when microdosing itself is the goal: to save on the cost of drugs, for example, or through fear of side-effects https://t.co/3VdyAn2QJJIllustration: Cristina Spano https://t.co/8fBgz1UqFM ...
Candada doesn't want a 'partial' trade agreement with the US
Yahoo Finance· 2026-07-21 18:10
And you know, what the issue has been for us has been a comprehensive agreement. We understand the US approach to strategic sectors, what they call strategic sectors. They are strategic sectors, but under their definition 232 definitions, that's aluminum, that's forest products, that's steel, that's automobiles, pharmaceuticals, copper, others.But those first four being the most important for the Canadian economy. And that uh we don't want a partial agreement. We want something that addresses those sectors ...
Full Episode: TODAY Show - July 21
NBC News· 2026-07-21 17:00
>>> GOOD TUESDAY MORNING. EVEN MORE DANGEROUS SUMMER WEATHER OVERNIGHT. >> THOSE STORMS NOW RACING ACROSS THE COUNTRY WITH MILLIONS IN THEIR PATH. IT IS JULY 21st. THIS IS "TODAY. " >>> BREAKING OVERNIGHT, A STRING OF TORNADOES TEARING THROUGH THE MIDWEST. THAT THREAT NOW PUSHING EAST, TARGETING MAJOR CITIES WITH HEAVY RAIN AND DAMAGING WINDS, WHILE DOWN SOUTH, PREPARATIONS UNDERWAY FOR TROPICAL STORM BERTHA SET TO LASH THE GULF COAST. WE'LL HAVE THE FULL FORECAST. >>> HONORING THE FALLEN. GROWING TRIBUTES ...
Novo Nordisk sues Eli Lilly in the US over obesity drug ads
Bloomberg Television· 2026-07-21 15:27
What Lilly is doing with its advertising campaign is taking the highest dose of its medicine and comparing it to a lower dose of the Novo medicine and then it is deceiving the people who see these campaigns into believing that the Lilly drug is greatly superior to the Novo drug. So it's it's not terribly complicated. They're using an old outdated study that that is a head-to-head study which is no longer current.And if they were using current data, it paints a very different picture. What we will show first ...